FDA Was Slow to Address Complaint About Abbott Infant Formula Factory, Audit Reveals

Reported about 1 year ago

An audit found that the U.S. Food and Drug Administration took over 15 months to respond to a whistleblower complaint regarding conditions at an Abbott Nutrition factory, which was linked to a nationwide infant formula shortage. The audit revealed that the FDA had inadequate policies to handle the issues at the Abbott plant, leading to delayed actions and inspections. This included a delayed inspection after a whistleblower complaint in October 2021 and a failure to promptly address contamination concerns that resulted in infant hospitalizations and deaths.

Source: YAHOO

View details

You may also interested in these wikis

Back to all Wikis